Artes App available for Android

We have opened a beta version of the Warriors chat for testing.
Artes Electronics company has launched a new product - a Skin cancer warriors chat, where anyone who has been diagnosed with melanoma can communicate directly with people who have survived cancer or are currently under treatment. The launch of the "Artes" app was specially timed for May, as it is the month of awareness about melanoma and skin cancer.

90% of melanoma survivors (based on an independent survey) who have been treated and achieved remission admit that they lacked support from "equal" people, that is, patients with the same diagnosis. Especially in the first few days. At the moment of acceptance and awareness of the diagnosis, it is important not to lock yourself in, but to talk to someone who will understand and help calm down, and tune in to the treatment of skin cancer with new energy. People who have already encountered melanoma are willing to share their experience, so Artes Electronics caught fire with the idea to simplify such communication and create a special application.

After 10 months of development, Artes Electronics has launched a beta version of the Artes chat. The app is free and from today is available for Android devices. The iOS version is being prepared for release at the end of May.

A little bit about the product: the app got its name from the first Greek library known to man, Artes. This library included works on various spheres of life at that time, including medicine. This name perfectly describes the goal that is laid in the app - a comprehensive approach to a person. Therefore, the chat of warriors with melanoma is only the first step, in the future new features related to health and self-care will be added to the Artes app.

Among the company's products can also find a device for self-examination of moles NOTA mole tracker, which helps to find dangerous changes in nevi at an early stage and sends them to the doctor on time. In the month of melanoma awareness, a 20% discount on the MAY20 promo code is valid on the device.
Subscribe to the newsletter or ask a question
Click to order
Your order
Step #1:Leave contact details for delivery and feedback.
Step #2: After adding contacts, you will be taken to the Stripe payment page, where you can pay for mole tracker and delivery in two clicks.
Your Name
Your Email
Your Phone
On the day of payment, we transmit the information to the delivery service. The delivery time to residents of the USA is 3 days, for the whole world - 14-19 days, depending on the recipient's address.
List of literature

1) Kurtis B. Reed, Jerry D. Brewer, Christine M. Lohse, Kariline E. Bringe, Crystal N. Pruitt, and Lawrence E. Gibson. Increasing Incidence of Melanoma Among Young Adults: An Epidemiological Study in Olmsted County, Minnesota.

2) Gandini S, Sera F, Cattaruzza MS, et al. Meta–analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer. 2005; 41:28–44. [PubMed: 15617989]

3) Olsen CM, Carroll HJ, Whiteman DC. Estimating the attributable fraction for cancer: A metaanalysis of nevi and melanoma. Cancer Prev Res (Phila). 2010; 3:233–245. [PubMed: 20086181]

4) Mitra D1, Luo X, Morgan A, Wang J, Hoang MP, Lo J, Guerrero CR, Lennerz JK, Mihm MC, Wargo JA, Robinson KC, Devi SP, Vanover JC, D'Orazio JA, McMahon M, Bosenberg MW, Haigis KM, Haber DA, Wang Y, Fisher DE. An ultraviolet–radiation–independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature. 2012 Nov 15;491(7424):449–53. doi: 10.1038/nature11624. Epub 2012 Oct 31.

5) Wu S, Han J, Laden F, Qureshi AA. Long–term ultraviolet flux, other potential risk factors, and skin cancer risk: a cohort study Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):1080–9. doi: 10.1158/1055–9965.EPI–13–0821.

6) Wheless L, Black J, Alberg AJ. Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1686–95. doi: 10.1158/1055–9965.EPI–10–0243. Epub 2010 Jun 22.

7) Vajdic CM, Chong AH, Kelly PJ, Meagher NS, Van Leeuwen MT, Grulich AE, Webster AC.

Survival after cutaneous melanoma in kidney transplant recipients: a population–based matched cohort study. Am J Transplant. 2014 Jun;14(6):1368–75. doi: 10.1111/ajt.12716. Epub 2014 Apr 14.

8) Risk of melanoma in people with HIV/AIDS in the pre– and post–HAART eras: a systematic review and meta–analysis of cohort studies. Olsen CM, Knight LL, Green AC. PLoS One. 2014 Apr 16;9(4):e95096. doi: 10.1371/journal.pone.0095096. eCollection 2014. Review.

9) Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol. 1987 Feb;123(2):241–50.

10) Udayakumar D, Tsao H. Melanoma genetics: an update on risk–associated genes. Hematol Oncol Clin North Am. 2009; 23:415–429. vii. [PubMed: 19464594] Authors review genes of variable risk implicated in CMM, most notably CDKN2A.

11) Pappo AS, Armstrong GT, Liu W, et al. Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: A report from the childhood cancer survivor study. Pediatr Blood Cancer. 2012

12) Indoor tanning and risk of melanoma: a case–control study in a highly exposed population.

Lazovich D1, Vogel RI, Berwick M, Weinstock MA, Anderson KE, Warshaw EM. Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1557–68. doi: 10.1158/1055–9965.EPI–09–1249. Epub 2010 May 26.